| |
| |
| Exchange: |
Nasdaq Small Cap |
| Security
Type: |
Common |
| Shares
Out: |
15,080,000 |
| Market
Cap: |
66.50(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$1.9 - $6.77 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : 44.6 |
| Insider 3/6 Months : 45.2 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Cumberland Pharmaceuticals is a pharmaceutical company engaged on the acquisition, development and commercialization of prescription products. Co.'s portfolio of brands include: Acetadote® (acetylcysteine) injection, for the treatment of acetaminophen poisoning; Caldolor® (ibuprofen) injection, for the treatment of pain and fever; Kristalose® (lactulose) for the treatment of constipation; Omeclamox®-Pak, (omeprazole, clarithromycin, amoxicillin) for the treatment of Helicobacter pylori infection and related duodenal ulcer disease; and Vaprisol® (conivaptan) injection, to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
5,022 |
10,463 |
38,850 |
| Total Buy Value |
$0 |
$16,861 |
$43,224 |
$80,715 |
| Total People Bought |
0 |
4 |
4 |
4 |
| Total Buy Transactions |
0 |
196 |
508 |
736 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2025-09-21 |
2025-06-20 |
2024-12-20 |
2023-12-21 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Kazimi A J |
Chairman and CEO |
• • • |
2025-11-28 |
4 |
A |
$2.41 |
$43 |
D/D |
18 |
5,700,885 |
|
- |
|
| Krogulski Kenneth |
Director |
– • – |
2025-11-28 |
4 |
A |
$2.41 |
$299 |
D/D |
124 |
294,622 |
|
- |
|
| Jones James |
Director |
– • – |
2025-11-28 |
4 |
A |
$2.41 |
$43 |
D/D |
18 |
44,793 |
|
- |
|
| Young Caroline |
Director |
– • – |
2025-11-28 |
4 |
A |
$2.41 |
$10 |
D/D |
4 |
33,243 |
|
- |
|
| Kazimi A J |
Chairman and CEO |
• • • |
2025-11-26 |
4 |
A |
$2.17 |
$39 |
D/D |
18 |
5,700,867 |
|
- |
|
| Krogulski Kenneth |
Director |
– • – |
2025-11-26 |
4 |
A |
$2.17 |
$269 |
D/D |
124 |
294,498 |
|
- |
|
| Jones James |
Director |
– • – |
2025-11-26 |
4 |
A |
$2.17 |
$39 |
D/D |
18 |
44,775 |
|
- |
|
| Young Caroline |
Director |
– • – |
2025-11-26 |
4 |
A |
$2.17 |
$9 |
D/D |
4 |
33,239 |
|
- |
|
| Kazimi A J |
Chairman and CEO |
• • • |
2025-11-25 |
4 |
A |
$2.21 |
$40 |
D/D |
18 |
5,700,849 |
|
- |
|
| Krogulski Kenneth |
Director |
– • – |
2025-11-25 |
4 |
A |
$2.21 |
$274 |
D/D |
124 |
294,374 |
|
- |
|
| Jones James |
Director |
– • – |
2025-11-25 |
4 |
A |
$2.21 |
$40 |
D/D |
18 |
44,757 |
|
- |
|
| Young Caroline |
Director |
– • – |
2025-11-25 |
4 |
A |
$2.21 |
$9 |
D/D |
4 |
33,235 |
|
- |
|
| Kazimi A J |
Chairman and CEO |
• • • |
2025-11-24 |
4 |
A |
$2.10 |
$38 |
D/D |
18 |
5,700,831 |
|
- |
|
| Krogulski Kenneth |
Director |
– • – |
2025-11-24 |
4 |
A |
$2.10 |
$260 |
D/D |
124 |
294,250 |
|
- |
|
| Jones James |
Director |
– • – |
2025-11-24 |
4 |
A |
$2.10 |
$38 |
D/D |
18 |
44,739 |
|
- |
|
| Young Caroline |
Director |
– • – |
2025-11-24 |
4 |
A |
$2.10 |
$8 |
D/D |
4 |
33,231 |
|
- |
|
| Kazimi A J |
Chairman and CEO |
• • • |
2025-11-21 |
4 |
A |
$1.96 |
$33 |
D/D |
17 |
5,700,813 |
|
- |
|
| Krogulski Kenneth |
Director |
– • – |
2025-11-21 |
4 |
A |
$1.96 |
$229 |
D/D |
117 |
294,126 |
|
- |
|
| Jones James |
Director |
– • – |
2025-11-21 |
4 |
A |
$1.96 |
$33 |
D/D |
17 |
44,721 |
|
- |
|
| Young Caroline |
Director |
– • – |
2025-11-21 |
4 |
A |
$1.96 |
$8 |
D/D |
4 |
33,227 |
|
- |
|
| Kazimi A J |
Chairman and CEO |
• • • |
2025-11-20 |
4 |
A |
$1.99 |
$34 |
D/D |
17 |
5,700,796 |
|
- |
|
| Krogulski Kenneth |
Director |
– • – |
2025-11-20 |
4 |
A |
$1.99 |
$233 |
D/D |
117 |
294,009 |
|
- |
|
| Jones James |
Director |
– • – |
2025-11-20 |
4 |
A |
$1.99 |
$34 |
D/D |
17 |
44,704 |
|
- |
|
| Young Caroline |
Director |
– • – |
2025-11-20 |
4 |
A |
$1.99 |
$8 |
D/D |
4 |
33,223 |
|
- |
|
| Kazimi A J |
Chairman and CEO |
• • • |
2025-11-19 |
4 |
A |
$2.01 |
$34 |
D/D |
17 |
5,700,779 |
|
- |
|
3652 Records found
|
|
Page 1 of 147 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.03 (0.68%) 
